<DOC>
	<DOCNO>NCT00081523</DOCNO>
	<brief_summary>This study treatment protocol experimental treatment involve . Study participant may see need clinical , translational basic research study , medically indicate . Subjects receive general medical care outside NIH see clinic CNHS varying frequency . Subjects may see multiple visit . Subjects may ask return additional testing need . Clinical care patient sickle cell disease provide appropriate Sickle Cell Clinic inpatient clinical center .</brief_summary>
	<brief_title>Natural History Sickle Cell Disease</brief_title>
	<detailed_description>This protocol permit establishment repository biospecimens individual affect sickle cell disease identify evaluate underlying disease mechanism ( ) , facilitate understanding pathogenesis natural history vaso-occlusive painful crisis complication disease . Patients evaluate medical history physical examination routine laboratory study obtain need assess diagnosis , disease activity , disease complication monitor treatment-related response toxicity . This protocol may also provide continued storage analysis clinical research data , biospecimens previously obtain NIH Institutional Review Board ( IRB ) -approved protocol subject consent . Patients eligible research protocol offer opportunity participate study sign informed consent obtain . Apart protocols , medical care additional tests/investigations recommend provided patient consistent routine standard practice provide consultation patient refer physician .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>INCLUSION CRITERIA : Individuals know suspected sickle cell disease 2 year age old Willingness capacity provide inform consent appropriate inform consent parent legal guardian Patients see sickle outpatient clinic one participate center ( CNHS NIH ) . EXCLUSION CRITERIA : Patient and/or guardian unable/unwilling give inform consent assent . Patients le 2 year age .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 13, 2017</verification_date>
	<keyword>Hemoglobin</keyword>
	<keyword>Pain Crisis</keyword>
	<keyword>Treatment Options</keyword>
	<keyword>Sickle Cell Disease</keyword>
	<keyword>Sickle Cell Trait</keyword>
	<keyword>Red Blood Cell Disorder</keyword>
	<keyword>Thalassemia</keyword>
	<keyword>Paroxysmal Nocturnal Hemoglobinuria</keyword>
	<keyword>Hemolytic Disorders</keyword>
</DOC>